Keyword: GlaxoSmithKline (GSK)


GSK to Buy Respiratory Drug Developer Aiolos Bio

10.01.2024 -

GSK has agreed to acquire biotech Aiolos Bio for a $1 billion upfront payment and up to $400 million for the achievement of certain milestones. Founded just last year...


GSK and Zhifei Co-Promote Shingles Vaccine in China

11.10.2023 -

GSK has struck a deal with Chongqing Zhifei Biological Products to promote the British group's shingles vaccine, Shingrix, in China for an initial three-year period...

Markets & Companies

Navigating Uncertainty in the Biopharma Market

17.05.2023 -

Biopharma companies are facing funding challenges in 2023 as interest rates rise and investors are becoming more risk adverse. There is hope on the horizon, say some...


European Drugmakers Slam EU Reform Proposals

27.04.2023 -

European NGOs have welcomed the EU’s plans for an overhaul of pharmaceutical legislation – the first in two decades – presented this week in Brussels. The drugs industry...


GSK Agrees Exclusive License for Novel Antifungal

03.04.2023 -

GSK is set to gain exclusive rights to first-in-class oral antifungal Brexafemme (ibrexafungerp) for treating vulvovaginal candidiasis (VVC) and recurrent VVC (RVVC) from...


Global Pharma Reduces Marketing Staff in India

21.03.2023 -

As part of what seems to be a general pattern of staff reductions in the pharmaceutical industry worldwide, a growing number of Western drugmakers are downsizing their...


GSK Prunes Ties with US Biotech Vir

20.02.2023 -

GSK is pruning its cooperation with Vir Biotechnology, turning away from Covid-19 antibody and vaccine research projects while continuing to collaborate with the company...


CureVac Presents Positive Data from mRNA Trials

01.02.2023 -

German biotech CureVac has released preliminary data from its ongoing cooperation with UK drugmaker GSK on a new class of “transformative medicines” based on messenger...